CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma

CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma

Abstract Background Cell division cycle 6 (CDC6) is a key licensing factor in the assembly of pre-replicative complexes at origins of replication. The role of CDC6 in the pathogenesis of in diffuse larger B-cell lymphoma (DLBCL) remains unknown. We aim to investigate the effects of CDC6 on the proli...

Full description

Bibliographic Details
Main Authors: Mingfang Shen, Yunfeng Zhang, Lun Tang, Qinyan Fu, Jiawei Zhang, Yang Xu, Hui Zeng, Yuan Li
Format: Article
Language:English
Published: BMC 2023-10-01
Series:BMC Cancer
Subjects:
CDC6
Diffuse large B cell lymphoma
Cell cycle
Apoptosis
Prognosis
Online Access:https://doi.org/10.1186/s12885-023-11186-6

Internet

https://doi.org/10.1186/s12885-023-11186-6

Similar Items